nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—CYP2B6—Rifampicin—leprosy	0.0875	0.113	CbGbCtD
Fluoxetine—CYP3A5—Thalidomide—leprosy	0.0712	0.092	CbGbCtD
Fluoxetine—CYP3A5—Rifampicin—leprosy	0.0689	0.0891	CbGbCtD
Fluoxetine—CYP2C19—Thalidomide—leprosy	0.0574	0.0742	CbGbCtD
Fluoxetine—CYP3A5—Dapsone—leprosy	0.0569	0.0735	CbGbCtD
Fluoxetine—CYP2C19—Rifampicin—leprosy	0.0556	0.0719	CbGbCtD
Fluoxetine—CYP1A2—Thalidomide—leprosy	0.053	0.0685	CbGbCtD
Fluoxetine—CYP1A2—Rifampicin—leprosy	0.0513	0.0663	CbGbCtD
Fluoxetine—CYP2C9—Thalidomide—leprosy	0.0477	0.0617	CbGbCtD
Fluoxetine—CYP2C9—Rifampicin—leprosy	0.0462	0.0597	CbGbCtD
Fluoxetine—CYP2C19—Dapsone—leprosy	0.0459	0.0593	CbGbCtD
Fluoxetine—ABCB1—Rifampicin—leprosy	0.0449	0.058	CbGbCtD
Fluoxetine—CYP2C9—Dapsone—leprosy	0.0382	0.0493	CbGbCtD
Fluoxetine—CYP3A4—Rifampicin—leprosy	0.0269	0.0347	CbGbCtD
Fluoxetine—CYP3A4—Dapsone—leprosy	0.0222	0.0287	CbGbCtD
Fluoxetine—Neck stiffness—Thalidomide—leprosy	0.00161	0.00736	CcSEcCtD
Fluoxetine—Grand mal convulsion—Thalidomide—leprosy	0.00161	0.00736	CcSEcCtD
Fluoxetine—Cerebral ischaemia—Thalidomide—leprosy	0.00159	0.00725	CcSEcCtD
Fluoxetine—Tongue discolouration—Thalidomide—leprosy	0.00159	0.00725	CcSEcCtD
Fluoxetine—Peripheral vascular disorder—Thalidomide—leprosy	0.00157	0.00715	CcSEcCtD
Fluoxetine—Nuchal rigidity—Thalidomide—leprosy	0.00148	0.00675	CcSEcCtD
Fluoxetine—Hostility—Thalidomide—leprosy	0.00139	0.00633	CcSEcCtD
Fluoxetine—Vesiculobullous rash—Thalidomide—leprosy	0.00137	0.00625	CcSEcCtD
Fluoxetine—Sexual dysfunction—Thalidomide—leprosy	0.00137	0.00625	CcSEcCtD
Fluoxetine—Suicide attempt—Thalidomide—leprosy	0.00135	0.00618	CcSEcCtD
Fluoxetine—Inappropriate antidiuretic hormone secretion—Thalidomide—leprosy	0.00132	0.00603	CcSEcCtD
Fluoxetine—Gastric ulcer—Thalidomide—leprosy	0.00132	0.00603	CcSEcCtD
Fluoxetine—Enlargement abdomen—Thalidomide—leprosy	0.00128	0.00583	CcSEcCtD
Fluoxetine—Psoriasis—Thalidomide—leprosy	0.00122	0.00558	CcSEcCtD
Fluoxetine—Myasthenia—Thalidomide—leprosy	0.00122	0.00558	CcSEcCtD
Fluoxetine—Hypothyroidism—Thalidomide—leprosy	0.0012	0.00546	CcSEcCtD
Fluoxetine—Galactorrhoea—Thalidomide—leprosy	0.00118	0.0054	CcSEcCtD
Fluoxetine—Menstrual disorder—Thalidomide—leprosy	0.00113	0.00514	CcSEcCtD
Fluoxetine—Seborrhoeic dermatitis—Thalidomide—leprosy	0.00113	0.00514	CcSEcCtD
Fluoxetine—Intestinal obstruction—Thalidomide—leprosy	0.00113	0.00514	CcSEcCtD
Fluoxetine—Neuralgia—Thalidomide—leprosy	0.0011	0.00504	CcSEcCtD
Fluoxetine—Hepatomegaly—Thalidomide—leprosy	0.00108	0.00495	CcSEcCtD
Fluoxetine—Thrombosis—Thalidomide—leprosy	0.00108	0.00495	CcSEcCtD
Fluoxetine—Metrorrhagia—Thalidomide—leprosy	0.00107	0.00491	CcSEcCtD
Fluoxetine—Hyperlipidaemia—Thalidomide—leprosy	0.00106	0.00486	CcSEcCtD
Fluoxetine—Psychotic disorder—Dapsone—leprosy	0.00106	0.00485	CcSEcCtD
Fluoxetine—Albuminuria—Thalidomide—leprosy	0.00103	0.00469	CcSEcCtD
Fluoxetine—Neuritis—Thalidomide—leprosy	0.00103	0.00469	CcSEcCtD
Fluoxetine—Stupor—Thalidomide—leprosy	0.00103	0.00469	CcSEcCtD
Fluoxetine—Pleural effusion—Thalidomide—leprosy	0.001	0.00458	CcSEcCtD
Fluoxetine—Amblyopia—Thalidomide—leprosy	0.000994	0.00454	CcSEcCtD
Fluoxetine—Skin ulcer—Thalidomide—leprosy	0.000986	0.0045	CcSEcCtD
Fluoxetine—Hyperaesthesia—Thalidomide—leprosy	0.000978	0.00446	CcSEcCtD
Fluoxetine—Rash pustular—Thalidomide—leprosy	0.000962	0.00439	CcSEcCtD
Fluoxetine—Muscular weakness—Dapsone—leprosy	0.00096	0.00438	CcSEcCtD
Fluoxetine—HTR2A—trigeminal nerve—leprosy	0.000946	0.134	CbGeAlD
Fluoxetine—Influenza—Dapsone—leprosy	0.000941	0.00429	CcSEcCtD
Fluoxetine—Petechiae—Thalidomide—leprosy	0.000933	0.00426	CcSEcCtD
Fluoxetine—Numbness—Thalidomide—leprosy	0.000926	0.00423	CcSEcCtD
Fluoxetine—Pancreatitis—Dapsone—leprosy	0.000922	0.00421	CcSEcCtD
Fluoxetine—Blood disorder—Thalidomide—leprosy	0.000919	0.0042	CcSEcCtD
Fluoxetine—Acne—Thalidomide—leprosy	0.000912	0.00416	CcSEcCtD
Fluoxetine—Apnoea—Thalidomide—leprosy	0.000905	0.00413	CcSEcCtD
Fluoxetine—Sensory loss—Thalidomide—leprosy	0.000886	0.00405	CcSEcCtD
Fluoxetine—Jaundice cholestatic—Thalidomide—leprosy	0.000874	0.00399	CcSEcCtD
Fluoxetine—Amenorrhoea—Thalidomide—leprosy	0.000874	0.00399	CcSEcCtD
Fluoxetine—Accidental injury—Thalidomide—leprosy	0.000867	0.00396	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Dapsone—leprosy	0.000859	0.00392	CcSEcCtD
Fluoxetine—Musculoskeletal stiffness—Thalidomide—leprosy	0.000856	0.00391	CcSEcCtD
Fluoxetine—Skin discolouration—Thalidomide—leprosy	0.00085	0.00388	CcSEcCtD
Fluoxetine—Arthropathy—Thalidomide—leprosy	0.000844	0.00385	CcSEcCtD
Fluoxetine—Hypocalcaemia—Thalidomide—leprosy	0.000838	0.00383	CcSEcCtD
Fluoxetine—Thinking abnormal—Thalidomide—leprosy	0.000838	0.00383	CcSEcCtD
Fluoxetine—Herpes simplex—Thalidomide—leprosy	0.000833	0.0038	CcSEcCtD
Fluoxetine—Oliguria—Thalidomide—leprosy	0.000833	0.0038	CcSEcCtD
Fluoxetine—Drug interaction—Thalidomide—leprosy	0.000827	0.00378	CcSEcCtD
Fluoxetine—Hyperuricaemia—Thalidomide—leprosy	0.000827	0.00378	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Dapsone—leprosy	0.000822	0.00375	CcSEcCtD
Fluoxetine—Dyskinesia—Thalidomide—leprosy	0.000817	0.00373	CcSEcCtD
Fluoxetine—Leukocytosis—Thalidomide—leprosy	0.000817	0.00373	CcSEcCtD
Fluoxetine—Hypercholesterolaemia—Thalidomide—leprosy	0.000812	0.0037	CcSEcCtD
Fluoxetine—Bone pain—Thalidomide—leprosy	0.000801	0.00366	CcSEcCtD
Fluoxetine—Atrioventricular block—Thalidomide—leprosy	0.000791	0.00361	CcSEcCtD
Fluoxetine—Sinusitis—Dapsone—leprosy	0.000787	0.00359	CcSEcCtD
Fluoxetine—Gait disturbance—Thalidomide—leprosy	0.000786	0.00359	CcSEcCtD
Fluoxetine—Blood uric acid increased—Thalidomide—leprosy	0.000782	0.00357	CcSEcCtD
Fluoxetine—Coordination abnormal—Thalidomide—leprosy	0.000782	0.00357	CcSEcCtD
Fluoxetine—Neck pain—Thalidomide—leprosy	0.000777	0.00355	CcSEcCtD
Fluoxetine—Phosphatase alkaline increased—Thalidomide—leprosy	0.000768	0.0035	CcSEcCtD
Fluoxetine—Pulmonary embolism—Thalidomide—leprosy	0.000768	0.0035	CcSEcCtD
Fluoxetine—Hepatocellular injury—Thalidomide—leprosy	0.000768	0.0035	CcSEcCtD
Fluoxetine—Hyperkalaemia—Thalidomide—leprosy	0.000754	0.00344	CcSEcCtD
Fluoxetine—Eructation—Thalidomide—leprosy	0.000754	0.00344	CcSEcCtD
Fluoxetine—Pharyngitis—Dapsone—leprosy	0.000747	0.00341	CcSEcCtD
Fluoxetine—Depressed level of consciousness—Thalidomide—leprosy	0.000741	0.00338	CcSEcCtD
Fluoxetine—Colitis—Thalidomide—leprosy	0.000737	0.00336	CcSEcCtD
Fluoxetine—Candida infection—Thalidomide—leprosy	0.000733	0.00335	CcSEcCtD
Fluoxetine—Blood urea increased—Thalidomide—leprosy	0.000725	0.00331	CcSEcCtD
Fluoxetine—Aplastic anaemia—Thalidomide—leprosy	0.000721	0.00329	CcSEcCtD
Fluoxetine—Neuropathy—Thalidomide—leprosy	0.000721	0.00329	CcSEcCtD
Fluoxetine—Dry eye—Thalidomide—leprosy	0.000709	0.00324	CcSEcCtD
Fluoxetine—Cramps of lower extremities—Thalidomide—leprosy	0.000705	0.00322	CcSEcCtD
Fluoxetine—Tinnitus—Dapsone—leprosy	0.000702	0.00321	CcSEcCtD
Fluoxetine—Oesophagitis—Thalidomide—leprosy	0.000701	0.0032	CcSEcCtD
Fluoxetine—Rash maculo-papular—Thalidomide—leprosy	0.000698	0.00319	CcSEcCtD
Fluoxetine—Lightheadedness—Thalidomide—leprosy	0.000687	0.00314	CcSEcCtD
Fluoxetine—Gynaecomastia—Thalidomide—leprosy	0.000687	0.00314	CcSEcCtD
Fluoxetine—Pulmonary oedema—Thalidomide—leprosy	0.000683	0.00312	CcSEcCtD
Fluoxetine—HTR2A—cranial nerve—leprosy	0.000674	0.0958	CbGeAlD
Fluoxetine—Hypertonia—Thalidomide—leprosy	0.000673	0.00307	CcSEcCtD
Fluoxetine—Hyperkinesia—Thalidomide—leprosy	0.000669	0.00306	CcSEcCtD
Fluoxetine—Mental disability—Thalidomide—leprosy	0.000666	0.00304	CcSEcCtD
Fluoxetine—Euphoric mood—Thalidomide—leprosy	0.000659	0.00301	CcSEcCtD
Fluoxetine—Lymphadenopathy—Thalidomide—leprosy	0.000653	0.00298	CcSEcCtD
Fluoxetine—Thrombophlebitis—Thalidomide—leprosy	0.000644	0.00294	CcSEcCtD
Fluoxetine—Diabetes mellitus—Thalidomide—leprosy	0.000641	0.00292	CcSEcCtD
Fluoxetine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000641	0.00292	CcSEcCtD
Fluoxetine—Gastroenteritis—Thalidomide—leprosy	0.000629	0.00287	CcSEcCtD
Fluoxetine—Deafness—Thalidomide—leprosy	0.000623	0.00284	CcSEcCtD
Fluoxetine—Vascular purpura—Thalidomide—leprosy	0.000623	0.00284	CcSEcCtD
Fluoxetine—Eczema—Thalidomide—leprosy	0.00062	0.00283	CcSEcCtD
Fluoxetine—Eye pain—Thalidomide—leprosy	0.000617	0.00282	CcSEcCtD
Fluoxetine—Cardiac failure congestive—Thalidomide—leprosy	0.000614	0.0028	CcSEcCtD
Fluoxetine—Injury—Thalidomide—leprosy	0.000606	0.00277	CcSEcCtD
Fluoxetine—Libido decreased—Thalidomide—leprosy	0.000601	0.00274	CcSEcCtD
Fluoxetine—Increased appetite—Thalidomide—leprosy	0.000593	0.00271	CcSEcCtD
Fluoxetine—Amnesia—Thalidomide—leprosy	0.000593	0.00271	CcSEcCtD
Fluoxetine—Dermatitis exfoliative—Thalidomide—leprosy	0.00059	0.0027	CcSEcCtD
Fluoxetine—Vertigo—Dapsone—leprosy	0.000589	0.00269	CcSEcCtD
Fluoxetine—Atrial fibrillation—Thalidomide—leprosy	0.000588	0.00268	CcSEcCtD
Fluoxetine—Dermatitis bullous—Thalidomide—leprosy	0.000583	0.00266	CcSEcCtD
Fluoxetine—Purpura—Thalidomide—leprosy	0.000578	0.00264	CcSEcCtD
Fluoxetine—SLC6A2—nerve—leprosy	0.000575	0.0817	CbGeAlD
Fluoxetine—Arthritis—Thalidomide—leprosy	0.000573	0.00262	CcSEcCtD
Fluoxetine—Cough—Dapsone—leprosy	0.000572	0.00261	CcSEcCtD
Fluoxetine—Hypoglycaemia—Thalidomide—leprosy	0.000571	0.00261	CcSEcCtD
Fluoxetine—Lethargy—Thalidomide—leprosy	0.000569	0.0026	CcSEcCtD
Fluoxetine—Cerebrovascular accident—Thalidomide—leprosy	0.000569	0.0026	CcSEcCtD
Fluoxetine—HTR2A—hindlimb—leprosy	0.000568	0.0808	CbGeAlD
Fluoxetine—Hyponatraemia—Thalidomide—leprosy	0.000559	0.00255	CcSEcCtD
Fluoxetine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000557	0.00254	CcSEcCtD
Fluoxetine—Diplopia—Thalidomide—leprosy	0.000557	0.00254	CcSEcCtD
Fluoxetine—Osteoarthritis—Thalidomide—leprosy	0.000557	0.00254	CcSEcCtD
Fluoxetine—Disturbance in sexual arousal—Thalidomide—leprosy	0.000553	0.00252	CcSEcCtD
Fluoxetine—Affect lability—Thalidomide—leprosy	0.000548	0.0025	CcSEcCtD
Fluoxetine—Migraine—Thalidomide—leprosy	0.000548	0.0025	CcSEcCtD
Fluoxetine—Psychotic disorder—Thalidomide—leprosy	0.000544	0.00248	CcSEcCtD
Fluoxetine—Face oedema—Thalidomide—leprosy	0.000538	0.00246	CcSEcCtD
Fluoxetine—Cardiac arrest—Thalidomide—leprosy	0.00053	0.00242	CcSEcCtD
Fluoxetine—Mood swings—Thalidomide—leprosy	0.000528	0.00241	CcSEcCtD
Fluoxetine—Ataxia—Thalidomide—leprosy	0.000524	0.00239	CcSEcCtD
Fluoxetine—Tachycardia—Dapsone—leprosy	0.000522	0.00238	CcSEcCtD
Fluoxetine—Dehydration—Thalidomide—leprosy	0.000518	0.00237	CcSEcCtD
Fluoxetine—Liver function test abnormal—Thalidomide—leprosy	0.000514	0.00235	CcSEcCtD
Fluoxetine—Dry skin—Thalidomide—leprosy	0.000511	0.00233	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Thalidomide—leprosy	0.000509	0.00232	CcSEcCtD
Fluoxetine—Hypokalaemia—Thalidomide—leprosy	0.000507	0.00232	CcSEcCtD
Fluoxetine—Breast disorder—Thalidomide—leprosy	0.000503	0.0023	CcSEcCtD
Fluoxetine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000502	0.00229	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Thalidomide—leprosy	0.000491	0.00224	CcSEcCtD
Fluoxetine—Muscular weakness—Thalidomide—leprosy	0.000491	0.00224	CcSEcCtD
Fluoxetine—HTR2A—appendage—leprosy	0.000488	0.0693	CbGeAlD
Fluoxetine—Abdominal distension—Thalidomide—leprosy	0.000485	0.00221	CcSEcCtD
Fluoxetine—Insomnia—Dapsone—leprosy	0.000484	0.00221	CcSEcCtD
Fluoxetine—Influenza—Thalidomide—leprosy	0.000482	0.0022	CcSEcCtD
Fluoxetine—Dysphagia—Thalidomide—leprosy	0.000482	0.0022	CcSEcCtD
Fluoxetine—Eosinophilia—Thalidomide—leprosy	0.000477	0.00218	CcSEcCtD
Fluoxetine—Bronchospasm—Thalidomide—leprosy	0.000474	0.00216	CcSEcCtD
Fluoxetine—Pancreatitis—Thalidomide—leprosy	0.000472	0.00216	CcSEcCtD
Fluoxetine—Angina pectoris—Thalidomide—leprosy	0.000469	0.00214	CcSEcCtD
Fluoxetine—Bronchitis—Thalidomide—leprosy	0.000463	0.00211	CcSEcCtD
Fluoxetine—Pancytopenia—Thalidomide—leprosy	0.000457	0.00209	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Thalidomide—leprosy	0.000448	0.00204	CcSEcCtD
Fluoxetine—Pollakiuria—Thalidomide—leprosy	0.000445	0.00203	CcSEcCtD
Fluoxetine—Erectile dysfunction—Thalidomide—leprosy	0.000444	0.00202	CcSEcCtD
Fluoxetine—HTR2A—peripheral nervous system—leprosy	0.000443	0.063	CbGeAlD
Fluoxetine—Photosensitivity reaction—Thalidomide—leprosy	0.00044	0.00201	CcSEcCtD
Fluoxetine—Weight increased—Thalidomide—leprosy	0.000438	0.002	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Dapsone—leprosy	0.000437	0.002	CcSEcCtD
Fluoxetine—Weight decreased—Thalidomide—leprosy	0.000436	0.00199	CcSEcCtD
Fluoxetine—Hyperglycaemia—Thalidomide—leprosy	0.000434	0.00198	CcSEcCtD
Fluoxetine—Pneumonia—Thalidomide—leprosy	0.000432	0.00197	CcSEcCtD
Fluoxetine—Drowsiness—Thalidomide—leprosy	0.000429	0.00196	CcSEcCtD
Fluoxetine—Depression—Thalidomide—leprosy	0.000428	0.00195	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000426	0.00194	CcSEcCtD
Fluoxetine—Acute coronary syndrome—Thalidomide—leprosy	0.000423	0.00193	CcSEcCtD
Fluoxetine—Abdominal pain—Dapsone—leprosy	0.000423	0.00193	CcSEcCtD
Fluoxetine—Body temperature increased—Dapsone—leprosy	0.000423	0.00193	CcSEcCtD
Fluoxetine—Renal failure—Thalidomide—leprosy	0.000422	0.00193	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Thalidomide—leprosy	0.000421	0.00192	CcSEcCtD
Fluoxetine—Myocardial infarction—Thalidomide—leprosy	0.000421	0.00192	CcSEcCtD
Fluoxetine—Stomatitis—Thalidomide—leprosy	0.000419	0.00191	CcSEcCtD
Fluoxetine—Conjunctivitis—Thalidomide—leprosy	0.000417	0.00191	CcSEcCtD
Fluoxetine—Sweating—Thalidomide—leprosy	0.000412	0.00188	CcSEcCtD
Fluoxetine—Haematuria—Thalidomide—leprosy	0.000409	0.00187	CcSEcCtD
Fluoxetine—Epistaxis—Thalidomide—leprosy	0.000405	0.00185	CcSEcCtD
Fluoxetine—Sinusitis—Thalidomide—leprosy	0.000403	0.00184	CcSEcCtD
Fluoxetine—Bradycardia—Thalidomide—leprosy	0.000392	0.00179	CcSEcCtD
Fluoxetine—Rhinitis—Thalidomide—leprosy	0.000386	0.00176	CcSEcCtD
Fluoxetine—Hepatitis—Thalidomide—leprosy	0.000385	0.00176	CcSEcCtD
Fluoxetine—Hypoaesthesia—Thalidomide—leprosy	0.000384	0.00175	CcSEcCtD
Fluoxetine—Pharyngitis—Thalidomide—leprosy	0.000383	0.00175	CcSEcCtD
Fluoxetine—Oedema peripheral—Thalidomide—leprosy	0.00038	0.00173	CcSEcCtD
Fluoxetine—Visual impairment—Thalidomide—leprosy	0.000371	0.0017	CcSEcCtD
Fluoxetine—Erythema multiforme—Thalidomide—leprosy	0.000364	0.00166	CcSEcCtD
Fluoxetine—Tinnitus—Thalidomide—leprosy	0.000359	0.00164	CcSEcCtD
Fluoxetine—Chills—Thalidomide—leprosy	0.000346	0.00158	CcSEcCtD
Fluoxetine—HTR2A—nerve—leprosy	0.000346	0.0491	CbGeAlD
Fluoxetine—Arrhythmia—Thalidomide—leprosy	0.000344	0.00157	CcSEcCtD
Fluoxetine—Alopecia—Thalidomide—leprosy	0.000341	0.00156	CcSEcCtD
Fluoxetine—Vomiting—Dapsone—leprosy	0.00034	0.00155	CcSEcCtD
Fluoxetine—Mental disorder—Thalidomide—leprosy	0.000338	0.00154	CcSEcCtD
Fluoxetine—Malnutrition—Thalidomide—leprosy	0.000336	0.00153	CcSEcCtD
Fluoxetine—Headache—Dapsone—leprosy	0.000335	0.00153	CcSEcCtD
Fluoxetine—Flatulence—Thalidomide—leprosy	0.000331	0.00151	CcSEcCtD
Fluoxetine—Tension—Thalidomide—leprosy	0.000329	0.0015	CcSEcCtD
Fluoxetine—Dysgeusia—Thalidomide—leprosy	0.000329	0.0015	CcSEcCtD
Fluoxetine—Nervousness—Thalidomide—leprosy	0.000326	0.00149	CcSEcCtD
Fluoxetine—Back pain—Thalidomide—leprosy	0.000325	0.00148	CcSEcCtD
Fluoxetine—Muscle spasms—Thalidomide—leprosy	0.000323	0.00147	CcSEcCtD
Fluoxetine—Nausea—Dapsone—leprosy	0.000318	0.00145	CcSEcCtD
Fluoxetine—Tremor—Thalidomide—leprosy	0.000314	0.00144	CcSEcCtD
Fluoxetine—Ill-defined disorder—Thalidomide—leprosy	0.000311	0.00142	CcSEcCtD
Fluoxetine—Anaemia—Thalidomide—leprosy	0.00031	0.00142	CcSEcCtD
Fluoxetine—Agitation—Thalidomide—leprosy	0.000308	0.00141	CcSEcCtD
Fluoxetine—Angioedema—Thalidomide—leprosy	0.000307	0.0014	CcSEcCtD
Fluoxetine—Malaise—Thalidomide—leprosy	0.000303	0.00138	CcSEcCtD
Fluoxetine—Vertigo—Thalidomide—leprosy	0.000301	0.00138	CcSEcCtD
Fluoxetine—Syncope—Thalidomide—leprosy	0.000301	0.00137	CcSEcCtD
Fluoxetine—Leukopenia—Thalidomide—leprosy	0.0003	0.00137	CcSEcCtD
Fluoxetine—Palpitations—Thalidomide—leprosy	0.000297	0.00135	CcSEcCtD
Fluoxetine—Loss of consciousness—Thalidomide—leprosy	0.000295	0.00135	CcSEcCtD
Fluoxetine—Cough—Thalidomide—leprosy	0.000293	0.00134	CcSEcCtD
Fluoxetine—Convulsion—Thalidomide—leprosy	0.000291	0.00133	CcSEcCtD
Fluoxetine—Hypertension—Thalidomide—leprosy	0.00029	0.00132	CcSEcCtD
Fluoxetine—Chest pain—Thalidomide—leprosy	0.000286	0.0013	CcSEcCtD
Fluoxetine—Arthralgia—Thalidomide—leprosy	0.000286	0.0013	CcSEcCtD
Fluoxetine—Myalgia—Thalidomide—leprosy	0.000286	0.0013	CcSEcCtD
Fluoxetine—Anxiety—Thalidomide—leprosy	0.000285	0.0013	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000284	0.0013	CcSEcCtD
Fluoxetine—Discomfort—Thalidomide—leprosy	0.000282	0.00129	CcSEcCtD
Fluoxetine—Dry mouth—Thalidomide—leprosy	0.000279	0.00128	CcSEcCtD
Fluoxetine—Confusional state—Thalidomide—leprosy	0.000276	0.00126	CcSEcCtD
Fluoxetine—Infection—Thalidomide—leprosy	0.000272	0.00124	CcSEcCtD
Fluoxetine—HTR2A—blood vessel—leprosy	0.000271	0.0386	CbGeAlD
Fluoxetine—SIGMAR1—eye—leprosy	0.000271	0.0385	CbGeAlD
Fluoxetine—Shock—Thalidomide—leprosy	0.000269	0.00123	CcSEcCtD
Fluoxetine—Thrombocytopenia—Thalidomide—leprosy	0.000268	0.00122	CcSEcCtD
Fluoxetine—Tachycardia—Thalidomide—leprosy	0.000267	0.00122	CcSEcCtD
Fluoxetine—Skin disorder—Thalidomide—leprosy	0.000266	0.00121	CcSEcCtD
Fluoxetine—Hyperhidrosis—Thalidomide—leprosy	0.000265	0.00121	CcSEcCtD
Fluoxetine—Anorexia—Thalidomide—leprosy	0.000261	0.00119	CcSEcCtD
Fluoxetine—Hypotension—Thalidomide—leprosy	0.000256	0.00117	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000249	0.00114	CcSEcCtD
Fluoxetine—Insomnia—Thalidomide—leprosy	0.000248	0.00113	CcSEcCtD
Fluoxetine—Paraesthesia—Thalidomide—leprosy	0.000246	0.00112	CcSEcCtD
Fluoxetine—Dyspnoea—Thalidomide—leprosy	0.000244	0.00111	CcSEcCtD
Fluoxetine—Somnolence—Thalidomide—leprosy	0.000243	0.00111	CcSEcCtD
Fluoxetine—Dyspepsia—Thalidomide—leprosy	0.000241	0.0011	CcSEcCtD
Fluoxetine—Decreased appetite—Thalidomide—leprosy	0.000238	0.00109	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Thalidomide—leprosy	0.000236	0.00108	CcSEcCtD
Fluoxetine—Fatigue—Thalidomide—leprosy	0.000236	0.00108	CcSEcCtD
Fluoxetine—Pain—Thalidomide—leprosy	0.000234	0.00107	CcSEcCtD
Fluoxetine—Constipation—Thalidomide—leprosy	0.000234	0.00107	CcSEcCtD
Fluoxetine—Feeling abnormal—Thalidomide—leprosy	0.000226	0.00103	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Thalidomide—leprosy	0.000224	0.00102	CcSEcCtD
Fluoxetine—Urticaria—Thalidomide—leprosy	0.000218	0.000993	CcSEcCtD
Fluoxetine—Body temperature increased—Thalidomide—leprosy	0.000216	0.000988	CcSEcCtD
Fluoxetine—Abdominal pain—Thalidomide—leprosy	0.000216	0.000988	CcSEcCtD
Fluoxetine—Hypersensitivity—Thalidomide—leprosy	0.000202	0.000921	CcSEcCtD
Fluoxetine—Asthenia—Thalidomide—leprosy	0.000196	0.000897	CcSEcCtD
Fluoxetine—Pruritus—Thalidomide—leprosy	0.000194	0.000885	CcSEcCtD
Fluoxetine—Diarrhoea—Thalidomide—leprosy	0.000187	0.000855	CcSEcCtD
Fluoxetine—Dizziness—Thalidomide—leprosy	0.000181	0.000827	CcSEcCtD
Fluoxetine—SIGMAR1—tendon—leprosy	0.00018	0.0255	CbGeAlD
Fluoxetine—ABCB1—blood vessel—leprosy	0.000178	0.0253	CbGeAlD
Fluoxetine—Vomiting—Thalidomide—leprosy	0.000174	0.000795	CcSEcCtD
Fluoxetine—Rash—Thalidomide—leprosy	0.000173	0.000788	CcSEcCtD
Fluoxetine—Dermatitis—Thalidomide—leprosy	0.000173	0.000788	CcSEcCtD
Fluoxetine—ORM1—nervous system—leprosy	0.000172	0.0245	CbGeAlD
Fluoxetine—Headache—Thalidomide—leprosy	0.000172	0.000783	CcSEcCtD
Fluoxetine—Nausea—Thalidomide—leprosy	0.000163	0.000743	CcSEcCtD
Fluoxetine—HTR2C—nervous system—leprosy	0.000155	0.022	CbGeAlD
Fluoxetine—CYP2B6—skin of body—leprosy	0.000154	0.0219	CbGeAlD
Fluoxetine—ALB—testis—leprosy	0.000154	0.0219	CbGeAlD
Fluoxetine—SIGMAR1—testis—leprosy	0.000149	0.0211	CbGeAlD
Fluoxetine—SLC6A4—nervous system—leprosy	0.000147	0.0209	CbGeAlD
Fluoxetine—HTR2A—eye—leprosy	0.000144	0.0205	CbGeAlD
Fluoxetine—SLC6A2—testis—leprosy	0.000132	0.0187	CbGeAlD
Fluoxetine—SLC6A2—nervous system—leprosy	0.000129	0.0184	CbGeAlD
Fluoxetine—CYP2B6—testis—leprosy	9.71e-05	0.0138	CbGeAlD
Fluoxetine—HTR2A—tendon—leprosy	9.57e-05	0.0136	CbGeAlD
Fluoxetine—CYP2B6—nervous system—leprosy	9.53e-05	0.0135	CbGeAlD
Fluoxetine—HTR2A—testis—leprosy	7.92e-05	0.0113	CbGeAlD
Fluoxetine—HTR2A—nervous system—leprosy	7.77e-05	0.011	CbGeAlD
Fluoxetine—CYP2D6—testis—leprosy	7.22e-05	0.0103	CbGeAlD
Fluoxetine—CYP3A4—nervous system—leprosy	7.2e-05	0.0102	CbGeAlD
Fluoxetine—CYP2D6—nervous system—leprosy	7.08e-05	0.0101	CbGeAlD
Fluoxetine—ABCB1—testis—leprosy	5.19e-05	0.00737	CbGeAlD
Fluoxetine—ABCB1—nervous system—leprosy	5.09e-05	0.00724	CbGeAlD
